PopulationsHumans
Employment, Volunteering, and Health‐Related Resource Use in Anti‐Amyloid in Asymptomatic Alzheimer's Disease (A4) Study
AAIC 2025 Abstract
Abstract
Background: “Pre‐symptomatic” Alzheimer's disease (AD), defined by the presence of brain amyloid in the absence of cognitive symptoms, has been identified as an ideal stage to target for the prevention of progression to cognitive impairment and dementia, but little is known about the health economic impact (including t

